<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: neck cancer</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Head and neck cancer survivors who use alcohol and cigarettes have increased death risk</title>
   	 <description>Cigarette smoking and alcohol consumption before head and neck cancer diagnosis strongly predicts the patient's future risk of death, according to published studies. Now, results of a new study show a similar effect among those who continued these habits after cancer diagnosis.</description>
     <link>http://www.physorg.com/news179089522.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 03 Dec 2009 23:40:01 EST</pubDate>
	 <guid isPermaLink="false">news179089522</guid>
</item>
<item>
     <title>DNA test could be key to targeting treatments for head and neck cancer</title>
   	 <description>It is estimated that more than 7,000 people are diagnosed with head and neck cancer each year in the UK and approximately 3,500 cases result in death.  These cancers include tumours of the mouth, lips,  throat and voice-box, and some have been linked to the sexually transmitted infection, HPV-16.  Scientists at Liverpool analysed the DNA of more than 90 cancerous tissue samples to look for genes that indicated infection.</description>
     <link>http://www.physorg.com/news173965456.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 05 Oct 2009 13:10:03 EST</pubDate>
	 <guid isPermaLink="false">news173965456</guid>
</item>
<item>
     <title>Study finds 231 new genes associated with head and neck cancer</title>
   	 <description>A Henry Ford Hospital study has identified 231 new genes associated with head and neck cancer, one of the most deadly cancers responsible for 2.1 percent of all cancer deaths in the United States.</description>
     <link>http://www.physorg.com/news173882707.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 04 Oct 2009 14:10:01 EST</pubDate>
	 <guid isPermaLink="false">news173882707</guid>
</item>
<item>
     <title>Incomplete radiation therapy common among medicare recipients with head and neck cancer</title>
   	 <description>Medicare recipients with head and neck cancer commonly do not complete radiation therapy without interruptions or at all, according to a report in the September issue of Archives of Otolaryngology-Head &amp; Neck Surgery. Patients who have surgery before radiation treatment appear more likely to complete therapy, whereas those who have other illnesses or who have chemotherapy first may be more likely to experience interruptions or discontinuation in radiation treatment.</description>
     <link>http://www.physorg.com/news172770691.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 21 Sep 2009 18:00:10 EST</pubDate>
	 <guid isPermaLink="false">news172770691</guid>
</item>
<item>
     <title>Post-treatment pain in head and neck cancer patients linked to recurrence, lower survival rate</title>
   	 <description>Patients with head and neck cancer who experience a higher level of post-treatment pain appear to have a lower survival rate than those who experience little or no post-treatment pain, according to a report in the August issue of Archives of Otolaryngology-Head &amp; Neck Surgery.</description>
     <link>http://www.physorg.com/news169752374.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 17 Aug 2009 19:20:01 EST</pubDate>
	 <guid isPermaLink="false">news169752374</guid>
</item>
<item>
     <title>Promising candidate protein for cancer prevention vaccines found</title>
   	 <description>Researchers at the University of Pittsburgh School of Medicine have learned that some healthy people naturally developed an immune response against a protein that is made in excess levels in many cancers, including breast, lung, and head and neck cancers. The finding suggests that a vaccine against the protein might prevent malignancies in high-risk individuals.</description>
     <link>http://www.physorg.com/news168607596.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 04 Aug 2009 12:27:59 EST</pubDate>
	 <guid isPermaLink="false">news168607596</guid>
</item>
<item>
     <title>Low prevalence of HPV infection may be tied to poor prognosis for blacks with head and neck cancer</title>
   	 <description>Researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer have found that head and neck cancer patients who test positive for the human papillomavirus (HPV) have much better survival rates than patients who don't have the virus, according to a new study in the journal Cancer Prevention Research. The researchers also discovered that blacks in the study had a very low rate of HPV infection, and consequently worse survival, which may explain why African-American patients traditionally have had a poor prognosis for head and neck cancer.</description>
     <link>http://www.physorg.com/news168095606.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 29 Jul 2009 14:50:02 EST</pubDate>
	 <guid isPermaLink="false">news168095606</guid>
</item>
<item>
     <title>New treatment combination proves safe for head and neck cancer patients</title>
   	 <description>Patients undergoing treatment for advanced head and neck cancers may respond well to the addition of gefinitib to chemotherapy, according to a study sponsored by the Eastern Cooperative Oncology Group and chaired by Ethan Argiris, M.D., associate professor of medicine, University of Pittsburgh School of Medicine, and co-leader of the Head and Neck Cancer Program of the University of Pittsburgh Cancer Institute (UPCI). The results will be disclosed at the 45th annual meeting of the American Society of Clinical Oncology (ASCO) on May 30 in Orlando, Fla.</description>
     <link>http://www.physorg.com/news162994786.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 31 May 2009 13:21:28 EST</pubDate>
	 <guid isPermaLink="false">news162994786</guid>
</item>
<item>
     <title>Cancer drug causes patient to lose fingerprints and be detained by US immigration</title>
   	 <description>Immigration officials held a cancer patient for four hours before they allowed him to enter the USA because one of his cancer drugs caused his fingerprints to disappear. His oncologist is now advising all cancer patients who are being treated with the commonly used drug, capecitabine, to carry a doctor's letter with them if they want to travel to the USA.</description>
     <link>http://www.physorg.com/news162626394.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 27 May 2009 07:00:34 EST</pubDate>
	 <guid isPermaLink="false">news162626394</guid>
</item>
<item>
     <title>HPV Linked to Certain Head and Neck Cancers (w/Videos)</title>
   	 <description>(PhysOrg.com) -- Researchers at Roswell Park Cancer Institute (RPCI) in Buffalo, New York, are strongly advocating a national discussion about the need to vaccinate both young men and women against HPV 16 to prevent head &amp; neck cancers. The call comes amid growing evidence that certain cancers of the head and neck are strongly linked to HPV 16, a specific strain of the human papillomavirus (HPV) that is one of the most common sexually transmitted diseases in the United States. It is estimated that approximately 70% of Americans, both men and women, will be infected with HPV at some point in their lives.</description>
     <link>http://www.physorg.com/news162153629.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 21 May 2009 19:41:19 EST</pubDate>
	 <guid isPermaLink="false">news162153629</guid>
</item>
<item>
     <title>From cars to cancer: Researcher employs auto industry tools for tumor therapy</title>
   	 <description>An effort is under way at the University of Houston to use technologies with origins in the automobile industry to develop new tools that will help doctors and technicians better plan radiation therapy for patients with head and neck cancer.</description>
     <link>http://www.physorg.com/news160820797.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 06 May 2009 09:27:23 EST</pubDate>
	 <guid isPermaLink="false">news160820797</guid>
</item>
<item>
     <title>Experimental drug shows promise against head and neck cancer</title>
   	 <description>A laboratory study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that an anti-cancer compound studied for treating blood cancers may also help in treating cancers of the head and neck. The work is reported in the April 28th online edition of the Journal of Pathology.</description>
     <link>http://www.physorg.com/news160153426.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 28 Apr 2009 16:05:55 EST</pubDate>
	 <guid isPermaLink="false">news160153426</guid>
</item>
<item>
     <title>New diagnostic advance seen for head, throat cancer</title>
   	 <description>Pharmacy researchers at Oregon State University today announced the discovery of a genetic regulator that is expressed at higher levels in the most aggressive types of head and neck cancers, in work that may help to identify them earlier or even offer a new therapy at some point in the future.</description>
     <link>http://www.physorg.com/news160152592.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 28 Apr 2009 15:50:44 EST</pubDate>
	 <guid isPermaLink="false">news160152592</guid>
</item>
<item>
     <title>Survey shows Americans may be missing direct route to head and neck cancer care</title>
   	 <description>Tens of thousands of Americans are diagnosed annually with head and neck cancers, but many adults are unaware of doctors who specialize in treating these conditions, according to a recent survey by the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS), the association representing America's ear, nose and throat (ENT) doctors.</description>
     <link>http://www.physorg.com/news159713768.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 23 Apr 2009 13:57:38 EST</pubDate>
	 <guid isPermaLink="false">news159713768</guid>
</item>
<item>
     <title>Acupuncture eases radiation-induced dry mouth in cancer patients</title>
   	 <description>Twice weekly acupuncture treatments relieve debilitating symptoms of xerostomia - severe dry mouth - among patients treated with radiation for head and neck cancer, researchers from The University of Texas M. D. Anderson Cancer Center report in the current online issue of Head &amp; Neck.</description>
     <link>http://www.physorg.com/news159456540.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 20 Apr 2009 14:29:29 EST</pubDate>
	 <guid isPermaLink="false">news159456540</guid>
</item>
<item>
     <title>Novel lung cancer vaccine shows promise in fighting early-stage lung cancer</title>
   	 <description>An experimental vaccine that triggers the patient's immune system to identify and attack specific tumor cells is showing new promise for the treatment of early lung cancer.  Thoracic surgeons at Rush University Medical Center are researching the vaccine called MAGE-A3 Antigen-Specific Cancer Immunotherapeutic, which is designed to kill cancer cells without harming normal cells. Rush is one of only five hospitals in Illinois offering the vaccine.</description>
     <link>http://www.physorg.com/news158244764.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 06 Apr 2009 13:53:20 EST</pubDate>
	 <guid isPermaLink="false">news158244764</guid>
</item>
<item>
     <title>Genetic changes outside nuclear DNA suspected to trigger more than half of all cancers</title>
   	 <description>A buildup of chemical bonds on certain cancer-promoting genes, a process known as hypermethylation, is widely known to render cells cancerous by disrupting biological brakes on runaway growth.  Now, Johns Hopkins scientists say the reverse process  - demethylation  - which wipes off those chemical bonds may also trigger more than half of all cancers.</description>
     <link>http://www.physorg.com/news157109078.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 24 Mar 2009 10:25:06 EST</pubDate>
	 <guid isPermaLink="false">news157109078</guid>
</item>
<item>
     <title>Researchers identify genetic markers for aggressive head and neck cancer</title>
   	 <description>Scientists at Albert Einstein College of Medicine of Yeshiva University have identified genetic markers that signal poor outcomes for patients with head and neck cancer. These findings could one day lead to a genetic test that could help select or predict successful treatment options for patients with this type of cancer. The results were published in the American Journal of Pathology.</description>
     <link>http://www.physorg.com/news156619491.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 18 Mar 2009 18:25:25 EST</pubDate>
	 <guid isPermaLink="false">news156619491</guid>
</item>
<item>
     <title>Survival of head and neck cancer patients is greatly affected by coexisting ailments</title>
   	 <description>Current estimates for head and neck cancer survival are largely inaccurate because they widely disregard many of the most common diseases such patients have in addition to their primary cancer, says Jay Piccirillo, M.D., a head and neck specialist at Washington University School of Medicine in St. Louis, the Siteman Cancer Center and Barnes-Jewish Hospital.</description>
     <link>http://www.physorg.com/news146333388.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 19 Nov 2008 16:09:48 EST</pubDate>
	 <guid isPermaLink="false">news146333388</guid>
</item>
<item>
     <title>Disparities in head and neck cancer patients</title>
   	 <description>A new analysis finds considerable disparities in survival related to race and socio-economic status among patients with head and neck cancer. Published in the November 15, 2008 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that earlier diagnosis and greater access to treatment could improve outcomes for these cancers among African Americans and the poor.</description>
     <link>http://www.physorg.com/news142481369.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 06 Oct 2008 03:09:29 EST</pubDate>
	 <guid isPermaLink="false">news142481369</guid>
</item>
<item>
     <title>As head and neck cancer risks evolve, more treatment options emerge</title>
   	 <description>Advances in understanding head and neck cancer over the last decade have led to more treatment options and improved quality of life for patients, according to a review published this week in the New England Journal of Medicine.</description>
     <link>http://www.physorg.com/news140287055.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 10 Sep 2008 17:37:35 EST</pubDate>
	 <guid isPermaLink="false">news140287055</guid>
</item>
<item>
     <title>Teamwork cuts out unnecessary biopsies, researchers find</title>
   	 <description>Unnecessary biopsies could be a thing of the past for patients undergoing treatment for head and neck cancer. New Saint Louis University research found that when nuclear medicine clinicians and treating physicians work together to interpret PET-CT scan results, the accuracy dramatically improves, sparring patients unnecessary pain and suffering.</description>
     <link>http://www.physorg.com/news135938072.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 22 Jul 2008 09:34:32 EST</pubDate>
	 <guid isPermaLink="false">news135938072</guid>
</item>
<item>
     <title>Has cancer spread? Research identifies best way to find answers so treatment can begin</title>
   	 <description>For patients with head and neck cancer, accurately determining how advanced the cancer is and detecting secondary cancers usually means undergoing numerous tests  - until now. New Saint Louis University research has found that the PET-CT scanner can be used as a stand-alone tool to detect secondary cancers, which occur in 5 to 10 percent of head and neck cancer patients.</description>
     <link>http://www.physorg.com/news135937990.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 22 Jul 2008 09:33:10 EST</pubDate>
	 <guid isPermaLink="false">news135937990</guid>
</item>


</channel>
</rss>

